The Online Investor
JNJ Buyback image

Johnson & Johnson Buyback

OLI recorded this information on 12/17/2018

Company: Johnson & Johnson
Buyback: JNJ buyback
$Amount Authorized: $5,000,000,000
Buyback Details: Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock.

Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.

Johnson and Johnson SEC Filing Email Alerts Service

Open the JNJ Page at The Online Investor »

Company Name: 
Johnson & Johnson
Stock buyback: 
JNJ buyback
Website: 
www.jnj.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding JNJ: 
140
Total Market Value Held by ETFs: 
$51.40B
Total Market Capitalization: 
$434.94B
% of Market Cap. Held by ETFs: 
11.82%
 

Open the JNJ Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.30 out of 4)
37th percentile
(ranked lower than approx. 63% of all stocks covered)

Analysts' Target Price:
JNJ Stock Forecast

Based on Zacks ABR data;
powered by Xignite

JNJ Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.